The efficacy of Cuscuta Chinensis on depressio
Phase 3
- Conditions
- Depression.Depressive episode
- Registration Number
- IRCT2015060722584N1
- Lead Sponsor
- Shiraz university of medical science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Inclusion: patients over 18 with the diagnosis of depression based on DSM5 and Beck criteria, patients with written informed consent.
Exclusion: Other underlying psychological disorder like Schizophrenia, schizoaffective, bipolar disorder, psychotic disorder, organic disorder make depression directly like hypothyroidism, pregnancy lactation, addiction, patients with suicidal thought and the patients. Who may need electronic convulsive therapy (ECT), being under the treatment of antidepressant on 1 month ago, chronic respiratory disease and past history of drug reaction to Cuscuta.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression. Timepoint: baseline , after intervention on second,4th and 6th week. Method of measurement: Beck depression inventory.
- Secondary Outcome Measures
Name Time Method Side effect like unusual drug reaction, GI discomfort. Timepoint: During the clinical trial specially on second,4th and 6th week. Method of measurement: By asking the patients.